Wesana Health Holdings Inc.
WSNAF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 4/30/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | -0.00 | 0.00 |
| FCF Yield | -153.87% | -1,043.40% | -46.32% | -0.06% |
| EV / EBITDA | -0.41 | -0.20 | -3.22 | -302.90 |
| Quality | ||||
| ROIC | 4,706.52% | -249.76% | -159.75% | 137.99% |
| Gross Margin | 0.00% | 0.00% | 30.52% | 33.53% |
| Cash Conversion Ratio | 0.42 | 2.43 | 0.35 | 0.20 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | – | – |
| Free Cash Flow Growth | 88.74% | 35.99% | -69,653.75% | 85.34% |
| Safety | ||||
| Net Debt / EBITDA | -0.11 | 0.05 | 0.95 | 14.53 |
| Interest Coverage | -145.77 | -41.87 | -721.13 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 242.99 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | -1,700.88 | -1,275.09 |